Logo image of AKZA.AS

AKZO NOBEL N.V. (AKZA.AS) Stock Fundamental Analysis

Europe - Euronext Amsterdam - AMS:AKZA - NL0013267909 - Common Stock

53.92 EUR
+0.06 (+0.11%)
Last: 11/24/2025, 7:00:00 PM
Fundamental Rating

3

AKZA gets a fundamental rating of 3 out of 10. The analysis compared the fundamentals against 74 industry peers in the Chemicals industry. While AKZA is still in line with the averages on profitability rating, there are concerns on its financial health. AKZA has a valuation in line with the averages, but on the other hand it scores bad on growth.


Dividend Valuation Growth Profitability Health

4

1. Profitability

1.1 Basic Checks

In the past year AKZA was profitable.
AKZA had a positive operating cash flow in the past year.
In the past 5 years AKZA has always been profitable.
AKZA had a positive operating cash flow in each of the past 5 years.
AKZA.AS Yearly Net Income VS EBIT VS OCF VS FCFAKZA.AS Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 2B 4B 6B

1.2 Ratios

AKZA's Return On Assets of 0.42% is in line compared to the rest of the industry. AKZA outperforms 45.95% of its industry peers.
Looking at the Return On Equity, with a value of 1.48%, AKZA is in line with its industry, outperforming 50.00% of the companies in the same industry.
With a Return On Invested Capital value of 3.70%, AKZA perfoms like the industry average, outperforming 58.11% of the companies in the same industry.
The Average Return On Invested Capital over the past 3 years for AKZA is in line with the industry average of 6.48%.
Industry RankSector Rank
ROA 0.42%
ROE 1.48%
ROIC 3.7%
ROA(3y)3.08%
ROA(5y)4%
ROE(3y)10.07%
ROE(5y)11.29%
ROIC(3y)5.38%
ROIC(5y)6.02%
AKZA.AS Yearly ROA, ROE, ROICAKZA.AS Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10 20 30 40 50

1.3 Margins

Looking at the Profit Margin, with a value of 0.56%, AKZA is in line with its industry, outperforming 47.30% of the companies in the same industry.
AKZA's Profit Margin has declined in the last couple of years.
AKZA's Operating Margin of 4.84% is in line compared to the rest of the industry. AKZA outperforms 55.41% of its industry peers.
In the last couple of years the Operating Margin of AKZA has remained more or less at the same level.
AKZA has a Gross Margin of 39.78%. This is comparable to the rest of the industry: AKZA outperforms 59.46% of its industry peers.
AKZA's Gross Margin has been stable in the last couple of years.
Industry RankSector Rank
OM 4.84%
PM (TTM) 0.56%
GM 39.78%
OM growth 3Y-9.79%
OM growth 5Y-1.14%
PM growth 3Y-16.36%
PM growth 5Y-2.73%
GM growth 3Y-0.19%
GM growth 5Y-1.09%
AKZA.AS Yearly Profit, Operating, Gross MarginsAKZA.AS Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20 40 60

3

2. Health

2.1 Basic Checks

AKZA has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
Compared to 1 year ago, AKZA has about the same amount of shares outstanding.
The number of shares outstanding for AKZA has been reduced compared to 5 years ago.
AKZA has a better debt/assets ratio than last year.
AKZA.AS Yearly Shares OutstandingAKZA.AS Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M 200M
AKZA.AS Yearly Total Debt VS Total AssetsAKZA.AS Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5B 10B 15B

2.2 Solvency

AKZA has an Altman-Z score of 2.01. This is not the best score and indicates that AKZA is in the grey zone with still only limited risk for bankruptcy at the moment.
With a Altman-Z score value of 2.01, AKZA is not doing good in the industry: 60.81% of the companies in the same industry are doing better.
The Debt to FCF ratio of AKZA is 10.17, which is on the high side as it means it would take AKZA, 10.17 years of fcf income to pay off all of its debts.
AKZA's Debt to FCF ratio of 10.17 is fine compared to the rest of the industry. AKZA outperforms 62.16% of its industry peers.
A Debt/Equity ratio of 0.93 indicates that AKZA is somewhat dependend on debt financing.
AKZA's Debt to Equity ratio of 0.93 is on the low side compared to the rest of the industry. AKZA is outperformed by 75.68% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.93
Debt/FCF 10.17
Altman-Z 2.01
ROIC/WACC0.66
WACC5.61%
AKZA.AS Yearly LT Debt VS Equity VS FCFAKZA.AS Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 2B 4B 6B 8B 10B

2.3 Liquidity

AKZA has a Current Ratio of 1.25. This is a normal value and indicates that AKZA is financially healthy and should not expect problems in meeting its short term obligations.
With a Current ratio value of 1.25, AKZA is not doing good in the industry: 75.68% of the companies in the same industry are doing better.
AKZA has a Quick Ratio of 1.25. This is a bad value and indicates that AKZA is not financially healthy enough and could expect problems in meeting its short term obligations.
AKZA has a Quick ratio (0.92) which is in line with its industry peers.
Industry RankSector Rank
Current Ratio 1.25
Quick Ratio 0.92
AKZA.AS Yearly Current Assets VS Current LiabilitesAKZA.AS Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2B 4B 6B 8B 10B

3

3. Growth

3.1 Past

AKZA shows a slight negative growth in Earnings Per Share. In the last year, the EPS has decreased by -2.93%.
The Earnings Per Share has been growing slightly by 4.44% on average over the past years.
The Revenue has decreased by -2.03% in the past year.
Measured over the past years, AKZA shows a small growth in Revenue. The Revenue has been growing by 2.92% on average per year.
EPS 1Y (TTM)-2.93%
EPS 3Y-1.33%
EPS 5Y4.44%
EPS Q2Q%-11.4%
Revenue 1Y (TTM)-2.03%
Revenue growth 3Y3.76%
Revenue growth 5Y2.92%
Sales Q2Q%-4.54%

3.2 Future

Based on estimates for the next years, AKZA will show a quite strong growth in Earnings Per Share. The EPS will grow by 8.58% on average per year.
AKZA is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 0.89% yearly.
EPS Next Y6.92%
EPS Next 2Y8.78%
EPS Next 3Y8.67%
EPS Next 5Y8.58%
Revenue Next Year-3.22%
Revenue Next 2Y-1.67%
Revenue Next 3Y-0.19%
Revenue Next 5Y0.89%

3.3 Evolution

The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
AKZA.AS Yearly Revenue VS EstimatesAKZA.AS Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2016 2018 2020 2022 2024 2026 2028 2030 2032 5B 10B 15B
AKZA.AS Yearly EPS VS EstimatesAKZA.AS Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2016 2018 2020 2022 2024 2026 2028 2030 2032 2 4 6

4

4. Valuation

4.1 Price/Earnings Ratio

With a Price/Earnings ratio of 14.81, AKZA is valued correctly.
Compared to the rest of the industry, the Price/Earnings ratio of AKZA indicates a somewhat cheap valuation: AKZA is cheaper than 77.03% of the companies listed in the same industry.
Compared to an average S&P500 Price/Earnings ratio of 25.65, AKZA is valued a bit cheaper.
With a Price/Forward Earnings ratio of 11.71, the valuation of AKZA can be described as very reasonable.
Compared to the rest of the industry, the Price/Forward Earnings ratio of AKZA indicates a somewhat cheap valuation: AKZA is cheaper than 79.73% of the companies listed in the same industry.
When comparing the Price/Forward Earnings ratio of AKZA to the average of the S&P500 Index (34.45), we can say AKZA is valued rather cheaply.
Industry RankSector Rank
PE 14.81
Fwd PE 11.71
AKZA.AS Price Earnings VS Forward Price EarningsAKZA.AS Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 50 100 150 200 250

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, AKZA is valued a bit more expensive than 60.81% of the companies in the same industry.
AKZA's Price/Free Cash Flow ratio is a bit cheaper when compared to the industry. AKZA is cheaper than 78.38% of the companies in the same industry.
Industry RankSector Rank
P/FCF 17.53
EV/EBITDA 15.09
AKZA.AS Per share dataAKZA.AS EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 20 40 60

4.3 Compensation for Growth

The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates AKZA does not grow enough to justify the current Price/Earnings ratio.
PEG (NY)2.14
PEG (5Y)3.33
EPS Next 2Y8.78%
EPS Next 3Y8.67%

3

5. Dividend

5.1 Amount

AKZA has a Yearly Dividend Yield of 3.67%.
AKZA's Dividend Yield is a higher than the industry average which is at 3.18.
AKZA's Dividend Yield is rather good when compared to the S&P500 average which is at 2.41.
Industry RankSector Rank
Dividend Yield 3.67%

5.2 History

The dividend of AKZA decreases each year by -21.52%.
Dividend Growth(5Y)-21.52%
Div Incr Years0
Div Non Decr Years4
AKZA.AS Yearly Dividends per shareAKZA.AS Yearly Dividends per shareYearly Dividends per share 2018 2019 2020 2021 2022 2023 2024 2025 2 4 6

5.3 Sustainability

AKZA pays out 691.38% of its income as dividend. This is not a sustainable payout ratio.
DP691.38%
EPS Next 2Y8.78%
EPS Next 3Y8.67%
AKZA.AS Yearly Income VS Free CF VS DividendAKZA.AS Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 2B 4B 6B
AKZA.AS Dividend Payout.AKZA.AS Dividend Payout, showing the Payout Ratio.AKZA.AS Dividend Payout.PayoutRetained Earnings

AKZO NOBEL N.V.

AMS:AKZA (11/24/2025, 7:00:00 PM)

53.92

+0.06 (+0.11%)

Chartmill FA Rating
GICS SectorMaterials
GICS IndustryGroupMaterials
GICS IndustryChemicals
Earnings (Last)10-22 2025-10-22/bmo
Earnings (Next)01-27 2026-01-27/amc
Inst Owners66.98%
Inst Owner ChangeN/A
Ins Owners0.04%
Ins Owner ChangeN/A
Market Cap9.22B
Revenue(TTM)10.40B
Net Income(TTM)58.00M
Analysts77.6
Price Target70.26 (30.3%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 3.67%
Yearly Dividend1.98
Dividend Growth(5Y)-21.52%
DP691.38%
Div Incr Years0
Div Non Decr Years4
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-6.89%
Min EPS beat(2)-7.4%
Max EPS beat(2)-6.38%
EPS beat(4)0
Avg EPS beat(4)-11.39%
Min EPS beat(4)-27.6%
Max EPS beat(4)-4.18%
EPS beat(8)1
Avg EPS beat(8)-8.1%
EPS beat(12)2
Avg EPS beat(12)-11.74%
EPS beat(16)4
Avg EPS beat(16)-11.18%
Revenue beat(2)0
Avg Revenue beat(2)-3.03%
Min Revenue beat(2)-5.13%
Max Revenue beat(2)-0.93%
Revenue beat(4)1
Avg Revenue beat(4)-1.62%
Min Revenue beat(4)-5.13%
Max Revenue beat(4)1.79%
Revenue beat(8)1
Avg Revenue beat(8)-1.51%
Revenue beat(12)3
Avg Revenue beat(12)-1.43%
Revenue beat(16)3
Avg Revenue beat(16)-1.57%
PT rev (1m)-1.6%
PT rev (3m)-0.71%
EPS NQ rev (1m)4.9%
EPS NQ rev (3m)4.3%
EPS NY rev (1m)-2.04%
EPS NY rev (3m)-2.39%
Revenue NQ rev (1m)-1.13%
Revenue NQ rev (3m)-1.13%
Revenue NY rev (1m)-0.49%
Revenue NY rev (3m)-1.33%
Valuation
Industry RankSector Rank
PE 14.81
Fwd PE 11.71
P/S 0.89
P/FCF 17.53
P/OCF 10.86
P/B 2.35
P/tB 63.17
EV/EBITDA 15.09
EPS(TTM)3.64
EY6.75%
EPS(NY)4.6
Fwd EY8.54%
FCF(TTM)3.08
FCFY5.7%
OCF(TTM)4.96
OCFY9.21%
SpS60.83
BVpS22.98
TBVpS0.85
PEG (NY)2.14
PEG (5Y)3.33
Graham Number43.39
Profitability
Industry RankSector Rank
ROA 0.42%
ROE 1.48%
ROCE 5.56%
ROIC 3.7%
ROICexc 4.33%
ROICexgc 8.48%
OM 4.84%
PM (TTM) 0.56%
GM 39.78%
FCFM 5.06%
ROA(3y)3.08%
ROA(5y)4%
ROE(3y)10.07%
ROE(5y)11.29%
ROIC(3y)5.38%
ROIC(5y)6.02%
ROICexc(3y)6.53%
ROICexc(5y)7.21%
ROICexgc(3y)12.06%
ROICexgc(5y)13.03%
ROCE(3y)9.71%
ROCE(5y)10.22%
ROICexgc growth 3Y-10.53%
ROICexgc growth 5Y-0.19%
ROICexc growth 3Y-9.99%
ROICexc growth 5Y-0.31%
OM growth 3Y-9.79%
OM growth 5Y-1.14%
PM growth 3Y-16.36%
PM growth 5Y-2.73%
GM growth 3Y-0.19%
GM growth 5Y-1.09%
F-Score5
Asset Turnover0.75
Health
Industry RankSector Rank
Debt/Equity 0.93
Debt/FCF 10.17
Debt/EBITDA 4.17
Cap/Depr 86.36%
Cap/Sales 3.1%
Interest Coverage 2.86
Cash Conversion 96.7%
Profit Quality 906.9%
Current Ratio 1.25
Quick Ratio 0.92
Altman-Z 2.01
F-Score5
WACC5.61%
ROIC/WACC0.66
Cap/Depr(3y)80.65%
Cap/Depr(5y)79.09%
Cap/Sales(3y)2.74%
Cap/Sales(5y)2.85%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-2.93%
EPS 3Y-1.33%
EPS 5Y4.44%
EPS Q2Q%-11.4%
EPS Next Y6.92%
EPS Next 2Y8.78%
EPS Next 3Y8.67%
EPS Next 5Y8.58%
Revenue 1Y (TTM)-2.03%
Revenue growth 3Y3.76%
Revenue growth 5Y2.92%
Sales Q2Q%-4.54%
Revenue Next Year-3.22%
Revenue Next 2Y-1.67%
Revenue Next 3Y-0.19%
Revenue Next 5Y0.89%
EBIT growth 1Y-49.8%
EBIT growth 3Y-6.39%
EBIT growth 5Y1.75%
EBIT Next Year36.41%
EBIT Next 3Y15.61%
EBIT Next 5Y9.68%
FCF growth 1Y-8.04%
FCF growth 3Y4.63%
FCF growth 5YN/A
OCF growth 1Y1.07%
OCF growth 3Y3.41%
OCF growth 5Y96.16%

AKZO NOBEL N.V. / AKZA.AS FAQ

What is the ChartMill fundamental rating of AKZO NOBEL N.V. (AKZA.AS) stock?

ChartMill assigns a fundamental rating of 3 / 10 to AKZA.AS.


Can you provide the valuation status for AKZO NOBEL N.V.?

ChartMill assigns a valuation rating of 4 / 10 to AKZO NOBEL N.V. (AKZA.AS). This can be considered as Fairly Valued.


How profitable is AKZO NOBEL N.V. (AKZA.AS) stock?

AKZO NOBEL N.V. (AKZA.AS) has a profitability rating of 4 / 10.


How financially healthy is AKZO NOBEL N.V.?

The financial health rating of AKZO NOBEL N.V. (AKZA.AS) is 3 / 10.


What is the earnings growth outlook for AKZO NOBEL N.V.?

The Earnings per Share (EPS) of AKZO NOBEL N.V. (AKZA.AS) is expected to grow by 6.92% in the next year.